Literature DB >> 32093572

Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review.

Henrieke W Schutte1, Floris Heutink1, David J Wellenstein1, Guido B van den Broek1, Frank J A van den Hoogen1, Henri A M Marres1, Carla M L van Herpen2, Johannes H A M Kaanders3, Thijs M A W Merkx4, Robert P Takes1.   

Abstract

OBJECTIVE: An increased interval between symptomatic disease and treatment may negatively influence oncologic and/or functional outcomes in head and neck cancer (HNC). This systematic review aims to provide insight into the effects of time to treatment intervals on oncologic and functional outcomes in oral cavity, pharyngeal, and laryngeal cancer. DATA SOURCES: PubMed, EMBASE, and Cochrane library were searched. REVIEW
METHODS: All studies on delay or time to diagnosis or treatment in oral, pharyngeal, and laryngeal cancer were included. Quality assessment was performed with an adjusted version of the Newcastle-Ottawa scale. Outcomes of interest were tumor volume, stage, recurrence, survival, patient-reported outcome measures (PROMs), toxicity, and functionality after treatment.
RESULTS: A total of 51 studies were included. Current literature on the influence of delay in HNC is inconsistent but indicates higher stage and worse survival with longer delay. The effects on PROMs, toxicity, and functional outcome after treatment have not been investigated. The inconsistencies in outcomes were most likely caused by factors such as heterogeneity in study design, differences in the definitions of delay, bias of results, and incomplete adjustment for confounding factors in the included studies.
CONCLUSION: Irrespective of the level of evidence, the unfavorable effects of delay on oncologic, functional, and psychosocial outcomes are undisputed. Timely treatment while maintaining high-quality diagnostic procedures and decision making reflects good clinical practice in our opinion. This review will pose practical and logistic challenges that will have to be overcome.

Entities:  

Keywords:  diagnostic delay; head and neck cancer; survival; therapeutic delay; time interval; tumor stage

Year:  2020        PMID: 32093572     DOI: 10.1177/0194599820906387

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  19 in total

1.  Head and Neck Cancer Stage at Presentation and Survival Outcomes Among Native Hawaiian and Other Pacific Islander Patients Compared With Asian and White Patients.

Authors:  Peter Kim Moon; Yifei Ma; Uchechukwu C Megwalu
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-07-01       Impact factor: 8.961

2.  Characteristics and in-hospital morbidity trends associated with oral and oropharyngeal cancers in Brazil.

Authors:  Deborah Gomes de Miranda Vargas; Amanda Ramos da Cunha; Livia Fernandes Probst; Edílson José Zafalon; Paulo Zárate Pereira; Elaine Pereira da Silva Tagliaferro; Alessandro Diogo De-Carli
Journal:  BMC Oral Health       Date:  2022-07-06       Impact factor: 3.747

3.  The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.

Authors:  Dafina Petrova; Zuzana Špacírová; Nicolás Francisco Fernández-Martínez; Ana Ching-López; Dunia Garrido; Miguel Rodríguez-Barranco; Marina Pollán; Daniel Redondo-Sánchez; Carolina Espina; Camila Higueras-Callejón; Maria José Sánchez
Journal:  PLoS Med       Date:  2022-10-20       Impact factor: 11.613

4.  Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer.

Authors:  N Patrik Brodin; Rafi Kabarriti; Clyde B Schechter; Mark Pankuch; Vinai Gondi; Shalom Kalnicki; Madhur K Garg; Wolfgang A Tomé
Journal:  Radiat Oncol       Date:  2021-01-21       Impact factor: 3.481

5.  The impact of the COVID-19 pandemic on hospitalizations for oral and oropharyngeal cancer in Brazil.

Authors:  Amanda Ramos da Cunha; José Leopoldo Ferreira Antunes; Manoela Domingues Martins; Stefano Petti; Fernando Neves Hugo
Journal:  Community Dent Oral Epidemiol       Date:  2021-03-01       Impact factor: 2.489

6.  Patterns of Technology Use Among Patients With Head and Neck Cancer and Implications for Telehealth.

Authors:  Chloe B Warinner; Tuna C Hayirli; Regan W Bergmark; Rosh Sethi; Eleni M Rettig
Journal:  OTO Open       Date:  2021-06-07

Review 7.  Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic.

Authors:  Albert Y Han; Jessa E Miller; Jennifer L Long; Maie A St John
Journal:  Otolaryngol Head Neck Surg       Date:  2020-06-02       Impact factor: 3.497

8.  Inclusion of oral health teams in primary health care promotes early diagnosis of oral and oropharyngeal cancers: a nationwide study.

Authors:  Deborah Gomes de Miranda Vargas; Livia Fernandes Probst; Amanda Ramos da Cunha; Elaine Pereira da Silva Tagliaferro; Edílson José Zafalon; Paulo Zárate-Pereira; Alessandro Diogo De-Carli
Journal:  BMC Oral Health       Date:  2021-06-18       Impact factor: 2.757

9.  Changes in head and neck oncologic practice during the COVID-19 pandemic.

Authors:  Robert M Brody; William Greer Albergotti; David Shimunov; Elizabeth Nicolli; Urjeet A Patel; Brianna N Harris; Andrés M Bur
Journal:  Head Neck       Date:  2020-06-11       Impact factor: 3.821

10.  Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical cases.

Authors:  Alyssa M Civantos; Ryan M Carey; Gary R Lichtenstein; John N Lukens; Roger B Cohen; Christopher H Rassekh
Journal:  Head Neck       Date:  2020-04-22       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.